HomeNewsGlobal Pharma

Merck to invest $132 million in MilliporeSigma in France

Merck to invest $132 million in MilliporeSigma in France

Merck KGaA will invest €130 million ($132 million) in its manufacturing arm—MilliporeSigma—to employ single-use assemblies at its facility in Molsheim, France. It will create more than 800 jobs by the end of 2028, the company said.

By the end of 2024, MilliporeSigma plans to begin operations at the new 37,000-square foot clean rooms provided by the investment, with full production levels reached later in the decade. The company also expects a new logistics warehouse and administrative building to be ready by the end of 2024.

More news about: global pharma | Published by Sudeep Soparkar | September - 15 - 2022 | 660

Last news about this category


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members